ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Expands Approval of Osimertinib in Lung Cancer

2.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Implant-based reconstruction linked to increased risk of breast lymphomas

5.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot